APPLICATION
ANDA075458
TYPE
ANDA
ORIGINAL APPROVAL
2000-08-22
LATEST ACTION
2017-09-05
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
ENALAPRILATDiscontinued
ENALAPRILAT 1.25MG/ML · INJECTABLE · INJECTION
Approval history
2017-09-05Labeling · Supplement 9 · standardAP
2003-06-13Labeling · Supplement 3AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.